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ABSTRACT 
In men, follicle-stimulating hormone (FSH) acts on the seminiferous tubules and 
enhances spermatogenesis. Recently, a candidate locus (rs2414095) for FSH levels was 
identified by a genome-wide association study (GWAS) in Chinese men. The 
rs2414095 SNP is found on the third intron of the cytochrome P450, family 19, 
subfamily A, peptide 1 (CYP19A1) gene encoding an aromatase. In the present study, 
we performed a replication study in 1687 Japanese men (901 from cohort 1 and 786 
from cohort 2) to assess whether this single nucleotide polymorphism (SNP) is 
associated with circulating FSH levels. Furthermore, we investigated whether the 
rs2414095 SNP is correlated with semen quality traits in 2015 Japanese men (1224 
from cohort 1 and 791 from cohort 2). The rs2414095 SNP was significantly associated 
with circulating FSH levels (βSTD = 0.15, P = 9.7 × 10-5), sperm concentration (βSTD = 
0.073, P = 0.032), and total sperm number (TSN) (βSTD = 0.074, P = 0.027) in a 
combined analysis of the two Japanese male cohorts. We successfully replicated, in 
Japanese men, the results of the previous GWAS for the rs2414095 SNP in Chinese 
men, and found that the rs2414095 SNP was related with sperm production. 
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INTRODUCTION 
 The gonadotropin-releasing hormone (GnRH) secreted by the hypothalamus, 
stimulates the production of luteinizing hormone (LH) and follicle-stimulating hormone 
(FSH) by the pituitary gland. LH acts on Leydig cells in the testes, and induces 
testosterone secretion.1,2 The main action of testosterone is the development of sexual 
characteristics and genitalia. Sex hormone-binding globulin (SHBG) binds to 50%−60% 
of the testosterone in circulation, and decreases the concentration of biologically active 
testosterone in circulation.3 Inhibin B is a peptide hormone, the synthesis and secretion 
of which is promoted by FSH. Secreted inhibin B in the circulation directly acts on 
adenohypophysis by a feedback mechanism, and specifically inhibits FSH secretion.4 In 
men, FSH stimulates Sertoli cells, and increases sperm production.5,6 Therefore, low 
levels of FSH decrease spermatogenesis. 
 It has been suggested that sex hormone levels are heritable.7,8 However, little is 
known about the genetic determinants of sex hormone levels. Recently, a genome-wide 
association study (GWAS) in 3495 healthy Chinese men revealed that the rs2414095 
SNP in cytochrome P450, family 19, subfamily A, polypeptide (CYP19A1) at 15q21.2 
was significantly associated with estradiol levels (P = 6.5 × 10-31) and FSH levels (P = 
1.6 × 10-16).9 Here, we conducted a replication study to assess whether the rs2414095 
SNP is associated with circulating FSH levels or other hormone levels (including 
testosterone, SHBG, LH, inhibin B, and calculated free testosterone (cFT)) levels in 
Japanese men. Furthermore, we conducted an association analysis for semen quality 
traits (including sperm concentration, semen volume, sperm motility, total sperm 
number (TSN), and/or total motile sperm number (TMSN)) to establish whether this 
SNP influences spermatogenesis. 
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MATERIALS AND METHODS 
 This study was approved by the ethics committees of the University of 
Tokushima and St. Marianna Medical University. All participants provided written 
informed consent. 
 
Two Japanese cohort samples 
Two Japanese cohorts, 1224 young men from the general Japanese population 
(cohort 1: aged 20.8 ± 1.7 years; mean ± SD) and 791 Japanese men of proven fertility 
(cohort 2: aged 31.2 ± 4.8 years; mean ± SD), were included in this study. Among 
these subjects, the hormone levels of 901 men from cohort 1 and of 786 men from 
cohort 2 were measured and used for the replication study for FSH levels, and samples 
from all subjects were used for the association analysis for semen quality. Some of the 
subjects in this study have been described in previous reports.10-19 Briefly, cohort 1 
subjects consisted of male university students from four study centers based in the 
urology departments of university hospitals in four Japanese cities (Kawasaki, 
Kanazawa, Nagasaki, and Sapporo). Cohort 2 subjects consisted of the partners of 
pregnant women who attended obstetric clinics in four Japanese cities (Sapporo, 
Kanazawa, Osaka, and Fukuoka). 
 
Measurement of clinical traits 
Age, body weight, and height were self-reported. Body mass index (BMI) was 
calculated from body weight and height. Blood samples were obtained and analyzed as 
previously described.11,12 Briefly, blood samples were drawn from the cubital vein of 
each subject usually in the mornings, to reduce the effect of diurnal variations in 
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hormone levels. Testosterone, SHBG, FSH, and LH levels were determined by using a 
time-resolved immunofluorometric assay (Delfia, Wallac; Turku, Finland), and inhibin 
B was measured by a specific two-sided enzyme immunometric assay (Serotec; 
Kidlington, UK) at the Department of Growth and Reproduction, Rigshospitalet, in 
Copenhagen, Denmark. cFT was calculated from a value of 1 × 109 mol/L for the 
association constant of SHBG to testosterone, a value of 3.6 × 104 mol/L for the 
association constant of albumin to testosterone, and a fixed plasma albumin 
concentration of 43 g/L using Vermeulen’s formula.20 Semen samples were obtained 
and analyzed by using standardized protocols as previously described.11,12 Briefly, 
semen samples were obtained by masturbation after sexual abstinence for at least 48 h 
and were ejaculated into clean, wide-necked, sterile, and nontoxic collection containers. 
The samples were protected from temperature extremes and were liquefied at 37°C 
prior to testing. The sperm concentration of each sample was assessed using a 
Bürker-Türk hemocytometer (Erma; Tokyo, Japan) after fixation with sodium 
bicarbonate–formaldehyde solution. Only sperm with tails were counted. Semen 
volume was measured with a graduated 5-mL syringe (Terumo; Tokyo, Japan). Sperm 
motility was assessed from 10 μL of well-mixed semen placed on a clean glass slide, 
covered, and then examined microscopically at 400× magnification at 37°C on a 
microscope stage. The motility assessment was repeated twice, and the average value 
from two samples was calculated. The sperm were assessed using the World Health 
Organization (WHO) motility classes A, B, C, and D (World Health Organization, 
1999). In this study, sperm categorized as class A or B were considered motile.  
 
Genotyping 
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Genomic DNA was extracted from the peripheral blood samples of subjects 
using a QIAamp DNA blood kit (Qiagen; Tokyo, Japan). The rs2414095 SNP was 
genotyped using TaqMan probes (C_15798408_20; Applied Biosystems; Tokyo, 
Japan) with the ABI 7900HT real-time PCR system (Applied Biosystems). 
 
Statistical analysis 
Hardy-Weinberg equilibrium (HWE) was assessed in the two cohorts by using 
Pearson chi-square test for genotypes. 
To minimize deviation from a normal distribution, the analyses for 
testosterone, SHBG, FSH, LH, inhibin B, and cFT were processed using natural 
log-transformed variables, and sperm concentration, semen volume, TSN, and TMSN 
were processed using square-root transformed values. The associations between the 
rs2414095 SNP and sex hormone values were assessed using a standardized multiple 
linear regression test under an additive genetic model with adjustments for age and 
BMI, and the associations between the rs2414095 SNP and semen quality traits were 
assessed using a standardized multiple linear regression test under an additive genetic 
model with adjustments for age, BMI, and ejaculation abstinence. Ejaculation 
abstinence and time from masturbation to test were additionally adjusted for in 
determining sperm motility and total motile sperm number. 
The results from the two cohorts were combined in a meta-analysis using the 
meta package for R, version 3.1.2 (http://www.R-project.org/). The extent of 
heterogeneity among studies was quantified by the I2 statistic21 and statistically 
assessed by Cochran’s Q test. If there was no heterogeneity, as determined by an I2 
statistic less than 50% or a P value greater than 0.1, a fixed-effects model using the 
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inverse variance method was used. Otherwise, the random-effects model using the 
DerSimonian and Laird method was used. 
All statistical analyses were performed using R, version 3.1.2, and statistical 
significance was considered at P values less than 0.05 (P < 0.05). 
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RESULTS 
The characteristics of circulating sex hormones obtained from the two 
Japanese male cohorts are presented in Supplementary Table S1 as previously 
reported.12,17, To investigate the associations between the rs2414095 SNP and 
circulating FSH levels, we genotyped the SNP in a total of 1687 men (901 from cohort 
1 and 786 from cohort 2). The allele frequencies of the SNP analyzed in each cohort 
are shown in Table 1. The missing genotyping rate of the rs2414095 SNP was 0.1%. 
The genotypes of the SNP were in HWE in the two cohorts. Multiple linear regression 
analyses under the additive genetic model revealed that the rs2414095 SNP was 
significantly correlated with circulating FSH levels in both cohorts (βSTD = 0.17, P = 
1.2 × 10-3 in cohort 1; βSTD = 0.12, P = 0.026 in cohort 2) (Table 1). In the 
meta-analysis of the two Japanese cohorts, we found that the rs2414095 SNP was 
significantly associated with circulating FSH levels (βSTD = 0.15, P = 9.7 × 10-5). The 
rs2414095 SNP contributed to 0.9% of variance in FSH levels. 
We next investigated the associations between the rs2414095 SNP and other 
circulating hormone levels (including testosterone, SHBG, LH, inhibin B, and cFT) in 
the two Japanese male cohorts. We found that the rs2414095 SNP was significantly 
associated with circulating inhibin B levels in cohort 1 (βSTD = 0.11, P = 0.030), but 
not in cohort 2 (Table 2). In the meta-analysis of the two Japanese cohorts, the 
rs2414095 SNP was significantly associated with circulating inhibin B levels (βSTD = 
0.076, P = 0.042). 
We hypothesized that the SNP associated with FSH levels might influence 
sperm production, because FSH contributes to spermatogenesis.5,6 To verify this, we 
performed an association study between the rs2414095 SNP and semen quality traits. 
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The characteristics of semen parameters obtained from the two Japanese cohorts are 
presented in the Supplementary Table S2 as previously reported.11,12,15,18 The SNP was 
genotyped in a total of 2015 men (1224 from cohort 1 and 791 from cohort 2). The 
effect allele frequencies of this SNP was 0.29 in cohort 1 and 0.30 in cohort 2, and the 
genotypes of the SNP were in HWE in the two cohorts. Multiple linear regression 
analyses under the additive genetic model revealed that the rs2414095 SNP was 
significantly associated with sperm concentration (βSTD = 0.11, P = 0.016), TSN (βSTD 
= 0.11, P = 0.012), and TMSN (βSTD = 0.098, P = 0.024) in cohort 1 (Table 3). 
However, this SNP did not display associations with semen parameters in cohort 2. In 
the meta-analysis of the two Japanese cohorts, we found that the rs2414095 SNP was 
significantly associated with sperm concentration (βSTD = 0.073, P = 0.032) and TNS 
(βSTD = 0.074, P = 0.027). 
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DISCUSSION 
 A recent GWAS reported that the rs2414095 SNP was significantly associated 
with FSH levels in Chinese men.9 In this replication study, the rs2414095 SNP was 
found to significantly associate with FSH levels in a combined analysis of two cohorts 
in Japanese men. Therefore, we successfully validated the results of the association of 
the rs2414095 SNP from the previous GWAS. 
 The rs2414095 SNP is located on the third intron of the CYP19A1 gene, which 
encodes aromatase. This enzyme is induced by FSH and LH secretion, and converts 
testosterone to estradiol (E2).22-24 Aromatase deficiency in men and women suppressed 
the concentration of estradiol, and elevated the concentrations of FSH and LH in 
circulation.25 The treatment of an aromatase inhibitor elevated serum FSH levels in 
non-obstructive azoospermia,26 in male breast cancer patients,27 and in boys with 
delayed puberty.28 Insertion29 or missense30-34 mutations in the coding region of the 
CYP19A1 gene can cause aromatase deficiency. Mutations in the splicing site were also 
found in aromatase deficient patients.34-36 Aromatase deficiency with mutations in the 
CYP19A1 gene resulted in markedly elevated FSH concentrations.31,33,37-40 In this study, 
the A allele of the rs2414095 SNP was positively correlated with circulating FSH levels. 
The previous GWAS study reported that the G allele of the rs2414095 SNP was 
positively correlated with estradiol levels,9 indicating that the A allele of this SNP was 
negatively correlated with estradiol levels. Although the relationship between the 
rs24154095 SNP and aromatase expression and activity is unknown, it is suggested that 
the positive correlation between the A allele of this SNP and circulating FSH levels 
might depend on a positive feedback mechanism through decrease in the circulating 
estradiol levels. The rs2414095 SNP was also related with circulating inhibin B levels. 
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Because the synthesis and secretion of inhibin B is promoted by FSH,4-6 it is suggested 
that the relationship between the rs2414095 SNP and inhibin B levels is an indirect 
connection through FSH levels. However, further studies are needed to elucidate the 
molecular mechanisms through which the rs24154095 SNP affects the respective 
circulating levels of FSH, E2 and inhibin B. 
 In this study, we found that the A allele of the rs2414095 SNP was positively 
correlated with sperm concentration and TSN. FSH activates Sertoli cells and induces 
spermatogenesis in the presence of testosterone.41 Therefore, the relationship between 
the rs2414095 SNP and sperm production may also be indirectly affected by FSH levels. 
Further replication studies using larger samples with different circulating FSH levels 
and low sperm concentrations such as azoospermic and/or oligozoospermic patients will 
be needed to provide compelling evidence for this association. 
 In summary, we replicated the association between the rs2414095 SNP and 
circulating FSH levels in Japanese men. In addition, we found that the rs2414095 SNP 
was associated with sperm production. It is suggested that the rs2414095 SNP has an 
indirect influence on spermatogenesis through regulating FSH levels. 
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